Global Ultra Low Freezers Market – Industry Trends and Forecast to 2030

Ultra Low Freezers Market Analysis and Size

The market is fragmented in nature, as it consists of many global players such as Thermo Fisher Scientific Inc., VWR International, LLC., Eppendorf SE, and PHC Corporation, among others. The presence of these companies produces competitive prices for ultra low freezer products across the region. Due to the presence of these players at regional and international levels, suppliers and manufacturers offer products with different specifications and characteristics in all budgets. The rising demand for ultra-low freezers and the use of blood components and vaccines globally is expected to drive market growth.

Data Bridge Market Research analyzes that the global ultra low freezers market is expected to reach the value of USD 909.26 million by 2030, at a CAGR of 5.4% during the forecast period. This market report also covers pricing analysis and technological advancements in depth.

Market Definition

Ultra low freezers, often abbreviated as ULT freezers, represent a specialized segment within the refrigeration industry. These are highly sophisticated and technologically advanced devices designed for the preservation of biological and pharmaceutical samples at extremely low temperatures. They are a crucial tool in scientific and medical research, besides in various industries such as biotechnology and pharmaceuticals. Marketed primarily to research institutions, laboratories, hospitals, and pharmaceutical companies, ultra-low freezers are indispensable for the long-term storage of valuable biological materials such as DNA, RNA, proteins, vaccines, and other temperature-sensitive samples. With the growing importance of life sciences research and the need for reliable cold storage solutions, the ultra-low freezer market has witnessed substantial growth, with manufacturers continually innovating to improve energy efficiency, temperature stability, and storage capacity.

Global Ultra Low Freezers Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:

Drivers

• Increasing Demand for Biopharmaceuticals and Vaccines

The rising demand for biopharmaceuticals and vaccines can be attributed to several interconnected factors. Firstly, advances in biotechnology and genomics have transformed the pharmaceutical industry. Techniques such as CRISPR-Cas9 have revolutionized gene editing, enabling the development of highly targeted treatments and vaccines. Secondly, increasing global health concerns, exemplified by the COVID-19 pandemic, have underscored the necessity of vaccines in controlling infectious diseases. Additionally, the emergence of antibiotic-resistant bacteria highlights the importance of continuous research and development in biopharmaceuticals and vaccines.

For instance,

• When the novel coronavirus SARS-CoV-2 emerged in late 2019, it quickly spread globally, causing a severe respiratory illness known as COVID-19. The rapid spread of the virus highlighted the urgent need for vaccines and treatments. Moreover, the surge in biopharmaceutical research and development, including gene therapies and monoclonal antibodies, has driven the demand for ultra-low freezers. These cutting-edge therapies often involve sensitive biological materials that must be stored at ultra-low temperatures to retain their efficacy.

• Rising Research and Development Activities in Life Sciences

The rising R&D activities in the life sciences represent a thriving and multifaceted domain at the intersection of biology, medicine, technology, and sustainability. This surge in R&D can be attributed to several interconnected factors.

Firstly, rapid technological advancements, such as genomics, CRISPR-Cas9 gene editing, and high-throughput screening, have revolutionized how scientists study and manipulate biological systems, fostering a fertile ground for innovation and discovery. These tools enable researchers to decode genomes, identify disease markers, and develop novel therapies with unprecedented precision.

Secondly, the persistent challenge of emerging diseases such as Zika and the seismic impact of the COVID-19 pandemic underscores the vital importance of life sciences R&D. Scientists are working tirelessly to develop vaccines, treatments, and diagnostics for these threats, highlighting the need for ongoing research to safeguard global health.

Opportunity

• Increasing Demand for Biopreservation and Biobanking

The increasing demand for biopreservation and biobanking can be attributed to several factors, reflecting the growing importance of these practices in various fields such as healthcare, pharmaceuticals, research, and personalized medicine.

Ultra low freezers are vital components in the biobanking infrastructure, providing the necessary storage conditions for preserving a wide range of biological samples. As biobanking facilities proliferate globally due to advancements in medical research, precision medicine, and pharmaceutical development, the demand for ultra low freezers is surging. Manufacturers in this market have the chance to innovate and offer advanced freezer models with features like energy efficiency and remote monitoring to meet the evolving needs of biobanks.

Restraint / Challenge

• Temperature Validation and Calibration of Ultra Low Freezers

Temperature validation and calibration for ultra low freezers is a critical process in various industries, such as healthcare, research, and pharmaceuticals, where these freezers are used to store sensitive and valuable materials, including vaccines, biological samples, and chemicals, at extremely low temperatures (typically between -40°C to -80°C). Accurate and consistent temperature control is essential to ensure the integrity and viability of these stored materials.

In addition, calibration and validation processes can be time-consuming and costly for users, as they may necessitate taking freezers offline temporarily, potentially disrupting operations and requiring additional resources for backup storage and staff training. These challenges can affect market dynamics by influencing the cost of ultra low freezers and adding complexity to their adoption, particularly for smaller organizations or those with limited budgets.

Thus, temperature validation and calibration of ultra low freezers are expected to challenge market growth.

Recent Developments

• In June 2023, BioLife Solutions, Inc., a leading developer and supplier of biotechnology products and services for Cell and Gene Therapy (CGT) and broader biopharmaceutical markets announced the launch of a new High Capacity Controlled Freezer (CRF) to expand its CRF range, now available in three different formats. This IntelliRate i67C benchtop freezer meets important customer needs for large-scale production of cell therapies.
• In April 2023, Eppendorf launched the Centrifuge 5427 R, the first hydrocarbon-cooled Eppendorf microcentrifuge that contributed to a more sustainable laboratory environment. With this offer, customers can now perform a variety of molecular and cell biology applications using a refrigeration unit that contains a natural refrigerant with near-zero global warming potential. This launch not only the individuals but also the planet.
• In October 2022, Thermo Fisher Scientific Inc. announced that it would expand its laboratory operations in Highland Heights, Kentucky, helping customers deliver life-changing medicines to patients. The current facility, which includes central lab and biomarker operations, provides biopharma customers with high-quality laboratory services to accelerate drug development. This will help the company expand its clinical diagnostics business across various regions in the world and help to increase its global presence in the market.
• In March 2021, Helmer Scientific is pleased to announce the launch of the GX solutions laboratory and plasma freezer for vaccines, medicines, blood therapy, and specimen storage. Powered by OptiCool technology, GX Solutions is the first professional medical freezer optimized for critical healthcare applications thanks to temperature performance, noise reduction, and lower energy consumption. At the same time, they use low global warming potential (GWP) technology to support environmental sustainability. This launch has helped the company to expand its freezers product portfolio.
• In September 2020, PHC Corporation announced the acquisition of 50.9% of the shares of Amelieff Corporation according to an agreement with the company, which according to Amelieff operates as a consolidated subsidiary of PHC Corporation. This acquisition will help PHC Corporation strengthen its healthcare services business.

Global Ultra Low Freezers Market Scope

The market is segmented into seven notable segments based on type, technology, degree of cooling, insulated material, application, end user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Product
• Freezer Parts and Accessories

On the basis of type, the market is segmented into product and freezer parts and accessories.

Technology

• Automated Freezers
• Semi- Automated Freezers

On the basis of technology, the market is segmented into automated freezers and semi-automated freezers.

Degree of Cooling

• -41°C to -86 °C Freezers
• -87°C to -150 °C Freezers
• -10°C to -40 °C Freezers

On the basis of degree of cooling, the market is segmented into -41°C to -86 °C freezers, -87°C to -150 °C freezers, and -10°C to -40 °C freezers.

Insulated Material

• Polyurethane Foam
• Vacuum Panels
• Others

On the basis of insulated material, the market is segmented into polyurethane foam, vacuum panels, and others.

Application

• Blood & Blood Products
• Biological Samples
• Drug Compounds
• Organs
• Others

On the basis of application, the market is segmented into blood & blood products, biological samples, drug compounds, organs, and others.

End User

• Hospitals
• Corporate Laboratories
• Pharmaceuticals Companies
• Bio-Banks
• Clinics
• Academic and Research Institutes
• Others

On the basis of end user, the market is segmented into hospitals, corporate laboratories, pharmaceuticals companies, bio-banks, clinics, academic and research institutes, and others.

Distribution Channel

• Direct Tenders
• Retail Sales
• Third Party Distributors

On the basis of distribution channel, the market is segmented into direct tenders, retail sales, and third party distributors.

Global Ultra Low Freezers Market Regional Analysis/Insights

The global ultra low freezers market is analyzed and market size insights and trends are provided by country, type, technology, degree of cooling, insulated material, application, end user, and distribution channel as referenced above.

The countries covered in this market report are U.S., Canada, Mexico, Germany, U.K., France, Italy, Russia, Spain, Netherlands, Switzerland, Belgium, Turkey, Rest of Europe, China, Japan, India, Australia, South Korea, Indonesia, Philippines, Thailand, Malaysia, Singapore, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, Saudi Arabia, South Africa, U.A.E., Egypt, Israel, and Rest of Middle East and Africa.

North America is expected to dominate the global ultra low freezers market due to rising demand for blood and blood components. The U.S. is expected to dominate in North America with the largest market share as this share is attributable to the presence of key market players. Rising demand for biopharmaceuticals and vaccines, technological advancements, and ultra low freezers are anticipated to fuel the market growth. China is expected to dominate Asia-Pacific as the strategic initiatives by the key market players are expanding significantly. Germany is expected to dominate Europe, due to rising research and development activities in life sciences.

The country section of the report also provides individual market-impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like downstream and upstream value chain analysis, technical trends, porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Market Share Analysis

The global ultra low freezers market competitive landscape provides details of the competitor. Details included are company overview, company financials, revenue generated, market potential, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus related to the market.

Some of the major market players operating in the global ultra low freezers market are Thermo Fisher Scientific Inc., BioLife Solutions Inc., PHC Corporation, Helmer Scientific Inc., BINDER GmbH, Eppendorf SE, Esco Micro Pte. Ltd., VWR International, LLC., Azbil Corporation, NuAire, Inc., LABCOLD, ARTICO, EVERMED s.r.l., AticoExport, Vestfrost Solutions, BIONICS SCIENTIFIC TECHNOLOGIES (P) LTD., REMI GROUP, B Medical Systems, BIOWAY CORPORATION, FUKUSHIMA GALILEI CO.LTD.

SKU-55225